4.7 Review

Development of calixarene-based drug nanocarriers

期刊

JOURNAL OF MOLECULAR LIQUIDS
卷 325, 期 -, 页码 -

出版社

ELSEVIER
DOI: 10.1016/j.molliq.2020.115246

关键词

Calixarene; Drug carrier; Assembly; Nanomaterial; Cancer therapy; Anti-tumor

资金

  1. national natural scientific foundation of China [21872120]
  2. priority academic program development of Jiangsu higher education institutions (PAPD)

向作者/读者索取更多资源

Calixarenes as drug carriers have excellent properties such as easy functionalization, multiple loading sites for drugs, and responsiveness to external stimuli. They can effectively load various drugs and facilitate sustained drug release. Additionally, the introduction of metal/metal oxides into calixarene-based drug carriers further improves therapeutic effects.
Chemotherapy is widely used for cancer treatment. However, many chemotherapeutic drugs are insoluble in water, and many show similar toxicities toward target cells and healthy cells. Hence, the research and development of drug carriers have attracted considerable attention. Calixarenes are a class of macrocyclic substances with excellent drug carrier properties including low cytotoxicity and no hemolytic activity. Calixarenes are easily functionalized at various sites on the upper and lower rims. Following modulation with the appropriate groups, calixarenes self-assemble or assemble with guest molecules into various nanostructures. In addition, calixarenes can form composite nanomaterials with metals and nonmetals. Drugs can be loaded into calixarene-based assodates by solubilization/encapsulation, host-guest reactions, and adsorption. These calixarene-based associates provide multiple loading sites for drugs, including the macrocydic cavity, micellar interior, and internal nanopore and nanocage. Thus, multi-drug delivery strategies can be developed. Furthermore, calixarene-based associates are also convenient to prepare; their structures are easy to adjust, and they can respond to external stimuli. This facilitates a sustained release of drugs, thus reducing drug side effects and improving drug efficacy. Additionally, because of the antibacterial/anticancer activities of metal/metal oxides, their introduction into the calixarene-based drug carrier platform further improves the therapeutic effect of drugs. These developments have opened up a broad prospect for the application of calixarene-based drug delivery platforms in tumor therapy. In this review, we summarize recent research progress for calixarene-based drug carriers, focusing on the construction of associates and drug loading and release performance. The challenges and prospects for future developments are also provided in this review. (C) 2020 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据